Combination therapy with 5-azacytidine plus beta-2'-deoxythioguanosine in adult acute leukemia.
D000208:Acute Disease; D000328:Adult; D001374:Azacitidine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003849:Deoxyguanosine / Q000031:analogs & derivatives; D003853:Deoxyribonucleosides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D013872:Thionucleosides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D003853:Deoxyribonucleosides; D013872:Thionucleosides; C010438:beta-2'-deoxythioguanosine; D003849:Deoxyguanosine; D001374:Azacitidine